Background Nowadays a wearable cardioverter defibrillator (WCD) is reccomended in current guidelines in patients with transient risk of sudden cardiac death (SCD). A crucial factor for the effectiveness of the WCD is adequate patient compliance. In literature patients wore WCD with different wearing time between first randomized trial and registries. Methods We evaluated the adherence to WCD in consecutively patients discharged from our cardiology department for potentially transient high risk of SCD, that wore the WCD from August 2017 to June 2024 after a systematic education session lasting 30 – 45 minutes. . They were followed through remote monitoring. Furthermore we have retrospectively administered a questionnaire of perceived health status used in France Wearit II registry Results Out of 116 patients recruited , with average age 65,8 ±11,1 years old and baseline average left ventricular ejection fraction (LVEF) 29,9±8,9,76,7% were males and 61% of these patients wore WCD for severe systolic disfunction in ischemic cardiac disease ,4% after removal of an infected ICD, 35% after newly diagnosed cardiomyopathy.The median daily WCD wear time was 60,5 days ±42,5 and 22,9±2,6 hours daily. No sex difference were found both in days (males 60±39 vs females 60±39 , p=0,5 ) than in hours ( m 23±1,5 vs f 22,45±4,9)Few patients ( only 4% ) wore the WCD for < 20 h per day . In univariate analysis age was lower but not significativly(median Age < 20 h 53,2±14,2 vs > 20 h 66,3±10,7, p=0,05)Regarding questionnaire the two items that patients most agreed with Were :”the WCD gives me pace of mind “ and “ I follow lifestyle modification reccomandation fraom physicians with respectively 71% and 70% patients responding “ Strongly agree “ or “ agree”. Conclusions In our experience after adequate training the patient adherence in wearing WCD is almost optimal as in European registries. Furthermore the use of WCD was generally positively associated with health and lifestyle benefits